New-generation power semiconductors… – Information Centre – Research & Innovation
An EU, industry, national and regional-funded research project has developed the next generation of energy-efficient power semiconductors, using gallium nitride...
Year: 2021
Like father like son: how brain hea… – Information Centre – Research & Innovation
Your father's exercise routine may have made you smarter according to EU-funded researchers studying how lifestyle choices affect brain function...
Sensing module keeps watch beneath the waves – Information Centre – Research & Innovation
EU-funded researchers have designed a standard instrument module to monitor conditions in the deep sea. As part of a Europe-wide...
VCU Health System finalizes acquisition of Riverside Tappahannock Hospital
VCU Health System has recently completed its acquisition of Riverside Tappahannock Hospital, a 67-bed facility in the upper Middle Peninsula...
OIG audit: CMS should improve hospital wage index adjustments for rural hospitals
The Centers for Medicare and Medicaid Services' hospital wage index system isn't doing enough to support facilities in the bottom...
Radicalism vs risk in the battle against corporate bureaucracy
The admin-encrusted, top-heavy superstructure of modern business makes a plump and enticing target. Gary Hamel, the motor-mouthed management thinker, has...
Wix Assessment 2020
If you are bringing your brick and mortar store online or planning to launch an eCommerce store, having a advertising...
What Does a Perfect App Store Screenshot Look Like?
Icons and screenshots are the first things the user deals with in the mobile application store. However, it does not...
Cigna officially sells group life, accident, and disability insurance business to New York Life
New York Life completed its $6.3 billion acquisition of Cigna's group life, accident, and disability insurance business, the company announced...
COVID-19 treatment is the first synthetic biological drug to receive FDA approval for Phase 3 trials
Carrimycin has become the world's first synthetic biological drug treatment for severe COVID-19 to receive U.S. Food and Drug Administration...
